BHVN - Biohaven Pharmaceutical Holding Co Ltd
Biohaven Pharmaceutical Holding Co Ltd Logo

BHVN - Biohaven Pharmaceutical Holding Co Ltd

https://www.biohaven.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
Neutral
BHVN FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - BHVN - Biohaven ( NYSE:BHVN )
Benzinga • 5 days, 16 hours ago • score: -0.03
NEW YORK, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. BHVN between March 24, 2023 and May 14, 2025, both dates inclusive ( the "Class Period" ) , of the important September 12, 2025 lead ...
Bearish
Deadline Alert: Biohaven Ltd. ( BHVN ) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - Biohaven ( NYSE:BHVN )
Benzinga • 1 week, 3 days ago • score: -0.16
LOS ANGELES, Sept. 04, 2025 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 12, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. ( "Biohaven" or the ...
Neutral
DEADLINE ALERT for BHVN and NEOG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Biohaven ( NYSE:BHVN ) , Neogen ( NASDAQ:NEOG )
Benzinga • 1 week, 4 days ago • score: -0.15
LOS ANGELES, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders in the United States. The company is headquartered in New Haven, Connecticut.

52W High
$55.70
52W Low
$12.79
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
3.50
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-2.19
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
12.47
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
11.55%
Institutions (25–75% balanced)
82.73%
Shares Outstanding
105,791,000
Float
88,381,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-7.46
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-2.96%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.1926
Previous
-0.0982
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025